AzTrials
AzTrials

AsthmaPhase 2TAJPlusNCT01938976

Efficacy of School-Based, Peer-Led Asthma and Smoking Prevention Program on CO1 Levels and Smoking Behavior Among Early Adolescents in Jordan

A Phase 2 study testing TAJ Plus (Adolescent Asthma Action in Jordan) Plus the added class smoke free pledge in people with Asthma and Tobacco, run by University of Technology, Sydney.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Study Hypotheses: 1. adolescents in intervention schools who are given Triple A program plus ASP will show more awareness in regards to cigarettee smoking health effects and less nicotine dependencethan those in the control schools who are given Triple A alone. 2. Read more about this study

Who is it for?
Ages 11 to 14 years, men only
Conditions the study is for
Asthma, Tobacco, Waterpipe
What is being tested?
TAJ Plus (Adolescent Asthma Action in Jordan) Plus the added class smoke free pledge
Could I receive a placebo?
No, everyone receives an active treatment
How many people
815 participants
Where
No sites listed yet
Study dates
Oct 2012to May 2013
Phase
Phase 2
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 11 to 14 years
  • Men only
  • No healthy volunteers
  • Child

Inclusion Criteria: students in grades 7 and 8 in Irbid city high schools, can speak and read in both Arabic and English, obtain parental agreement, attend regular school.

-

Exclusion Criteria:students with other chronic diseases (rather than asthma),

-

About this study

Official title: Efficacy of School-Based, Peer-Led Asthma and Smoking Prevention Program on CO1 Levels, Nicotine Dependence, and Smoking Behavior Among Early Adolescents in Jordan

Study Hypotheses:

  1. adolescents in intervention schools who are given Triple A program plus ASP will show more awareness in regards to cigarettee smoking health effects and less nicotine dependencethan those in the control schools who are given Triple A alone.
  2. adolescents with asthma in intervention schools who are given Triple A program plus ASP will show less asthma symptoms and better control than those in the control schools who are given Triple A alone.
  3. adolescent smokers and passive smokers will exhibit higher levels of carbon monoxide (CO) in their breath than those who are not active or passive smokers.
  4. there is a positive correlation between self-report questions regarding student smoking status and levels of CO in their breath
Being tested
TAJ Plus (Adolescent Asthma Action in Jordan) Plus the added class smoke free pledge
Keywords
Asthma, Tobacco, Waterpipe, Cigarettes, Adolescents, Peer education, Jordan
Medical subject headings
Asthma, Water Pipe Smoking

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • TAJ Plus (Adolescent Asthma Action in Jordan) Plus the added class smoke free pledgeBehavioural

    Also called Triple A in Jordan (TAJ)

    Its is a school-based peer-led asthma and smoking prevention program that aims at improving asthma control and lowering nicotine dependence among smokers.

Study groups in NCT01938976
Study groupRoleWhat they receive
Adolescent Asthma ActionExperimentalAdolescent Asthma Action in Jordan (TAJ) Plus the added class smoke free pledge will be implemented in high schools in Jordan and will be compared to the TAJ alone for its efficacy in decreasing smoking rates, lowering CO1 levela and nicotine dependence.
Receives: Behavioral: TAJ Plus (Adolescent Asthma Action in Jordan) Plus the added class smoke free pledge
TAJExperimentalTAJ Plus the class smoke free pledge will be implemented in high schools in Jordan and compared to TAJ alone
Receives: Behavioral: TAJ Plus (Adolescent Asthma Action in Jordan) Plus the added class smoke free pledge

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. nicotine dependence level

    Self-administered nicotine dependence scale will be used in order to measure nicotine dependence level for adolescent smokers and passive smokers

    Measured: 3 months

  2. Asthma Contol level

    The pictorial version of the asthma control test will be measured for adolescents with asthma and recent wheezing

    Measured: 3 months

Secondary outcomes (2)
  1. Carbon monoxide (CO) breath test

    CO levels will be tested in adolescents' breath

    Measured: 3 months

  2. knowledge about health effects of cigarettee smoking

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Sep 2013 (estimated)
  2. Study startOct 2012
  3. Primary completionMar 2013
  4. Study completionMay 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
815 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01938976
Sponsor's protocol ID
96/2012
Acronym
TAJPlus
Status last verified
Sep 2013
First submitted
5 Sep 2013
Last updated
10 Sep 2013
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing TAJ Plus (Adolescent Asthma Action in Jordan) Plus the added class smoke free pledge in people with Asthma and Tobacco, run by University of Technology, Sydney.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 10 Sep 2013. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

nicotine dependence level (time frame: 3 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Sep 2013.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in